| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.091 | 0.001 |